Mail

"The EU must first support home-grown researchers until they can compete on a level playing field with US scientists." Putting companies on notice As a public relations counselor, I agree completely with your requirement that companies seeking coverage should provide news, not "unquestioning boosterism."1 They should understand that real news about their products serves their interests, not just the journalist. At the same time,

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

As a public relations counselor, I agree completely with your requirement that companies seeking coverage should provide news, not "unquestioning boosterism."1 They should understand that real news about their products serves their interests, not just the journalist. At the same time, I disagree that "boosterism" is "public relations." Real public relations is essentially good performance, well communicated. It has substance. For example, the CEO who refuses to discuss the future of his workforce may cause enormous damage to the morale of his employees. Good public relations is telling employees what you know when you know it about the future of their company and their paycheck. I applaud your efforts to require hard facts in your coverage. Your readers and the companies you cover are well served by that commitment.

David Meeker, Esq.
Edward Howard Public Relations
Cleveland, Ohio
DMeekerdm1@aol.com

In your April issue, you celebrated the 50 years with interferons ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies